Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LoDoCo2 colchicine in stable coronary artery disease
ACTRN12614000093684Phase 3Completed
- Sponsor
- Heart Research Institute
- Start
- Sep 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in coronary arteriosclerosis comparing Colchicine with Placebo (2 arms). Primary endpoint: Primary composite cardiovascular endpoint. Started Sep 2014; status: completed.
02
Drugs
colchicine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ACTRN12614000093684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000093684.